Disregulation of E-cadherin in transgenic mouse models of liver cancer
- 1 September 2004
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 84 (9) , 1137-1147
- https://doi.org/10.1038/labinvest.3700147
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesionPublished by Elsevier ,2002
- Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic ProgressionCell, 2002
- Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesisOncogene, 2000
- Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of β-catenin and synergistic effect of p53 null allelesOncogene, 2000
- E-cadherin Is a WT1 Target GeneJournal of Biological Chemistry, 2000
- The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cellsNature Cell Biology, 2000
- Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separatelyOncogene, 1999
- Regulation of E-Cadherin Gene Expression during Tumor Progression: The Role of a New Ets-Binding Site and the E-pal ElementExperimental Cell Research, 1999
- E–Cadherin Is Involved in the Intrahepatic Metastasis of Hepatocellular CarcinomaHepatology, 1996
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992